Caroline Robert

58PUBLICATIONS
361CO-AUTHORS
Gene and molecular therapyMolecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (58)

|Sep 22, 2026
Transcriptomic Plasticity and Its Spatial Architecture Shape Melanoma Response to Immunotherapy and Its Combination With BRAF/MEKi.

|Aug 12, 2026
COMBI-I: Long-Term Overall Survival With Spartalizumab Plus Dabrafenib and Trametinib in BRAF V600-Mutant Advanced Melanoma.

|Aug 11, 2026
Neoadjuvant Intralesional Daromun (L19IL2/L19TNF) in Resectable Locally Advanced Melanoma: An Update on the Efficacy and Safety Results of the PIVOTAL Phase III Trial.

|Jul 20, 2026
Selective mRNA translation determines adaptative mutability of melanoma cells to anti-BRAF/MEK combination therapy.

|Jul 02, 2026
Years of life lost in patients with a false-negative diagnosis of primary melanoma. A prospective study of the German Central Malignant Melanoma Registry involving 9063 patients over 28 years.

|Jun 08, 2026
Cancer Chemoimmunotherapy: Time Will Tell.

Pageof 10

Frequent Collaborators

23 joint publications

Paolo Antonio Ascierto

19 joint publications

Dirk Schadendorf

17 joint publications

Georgina V Long

12 joint publications

Reinhard Dummer